MERTK and retinitis pigmentosa: PTC124 (10 μg/mL) was shown to restore the expression of MERTK protein and RPE phagocytic activity (12% of control RPE level), which suggests that ataluren can be used to treat retinitis pigmentosa due to nonsense variants in MERTK, which has no effective therapies so far [88].